GE Healthcare announced that Centricity Practice Solution and Centricity Electronic Medical Record (EMR) have been certified to the ONC 2015 Edition certification criteria, the most recent ONC criteria available. This certification will assist eligible healthcare professionals and clinicians in attesting for Stage 3 Meaningful Use measures and fully implemented Medicare Incentive Payment System (MIPS) measures. The Meaningful Use measures from …

DiA Imaging Analysis announced that it has signed a multi-year, non-exclusive licensing and professional services agreement with GE Healthcare. DiA intends to develop its automated imaging analysis technology to work with GE Healthcare’s ultrasound devices. DiA has marketed its automated imaging analysis technology to deliver immediate, accurate, and reproducible imaging interpretation of ultrasound for point of care settings. These tools …

At a ribbon-cutting ceremony involving company executives and government officials, Varian Medical Systems (NYSE: VAR) announced the opening of its new facility in Jundiai, Brazil. One of its most comprehensive regional centers, Varian’s new 50,600-square foot facility is located in the Multivias Industrial Park and currently features a demonstration room, two training classrooms and a fully-equipped Varian Trilogy® linear accelerator …

Enopace Biomedical announced that it has been selected by leading cardiologists and industry professionals at the annual Shark Tank Innovation Competition in 2017 as a premier medical innovation company. The vote took place at the Transcatheter Cardiovascular Therapeutics (TCT) conference, which took place from October 29 to November 2 , 2017 in Denver, Colorado . The TCT conference is the …

LivaNova PLC and MicroPort Scientific Corporation announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures. CRM …

The U.S. Food and Drug Administration approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the programming process. “Programming adjustments to a cochlear implant are performed …

PENTAX Medical Company announced its OPTIVISTA EPK-i7010 Video Processor has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven healthcare performance improvement company in the country. The designation was based on direct feedback from hospital experts who interacted with the OPTIVISTA at the Vizient Innovative Technology Exchange in Denver on Sept. 14, 2017. The OPTIVISTA offers physicians …

Roche announced the launch of the DISCOVERY Teal HRP kit1, the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell populations in tissue-based research. DISCOVERY Teal HRP (horseradish peroxidase) kit can be used in combination with other detection kits, expanding the multiplexing capability of both immunohistochemistry (IHC) and in situ hybridization (ISH) …

Quest Diagnostics announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical lab network serving patients and providers in the Greater Los Angeles Area. CLA’s operations and patients were previously supported by caregivers and the laboratory at Providence Saint Joseph Medical Center in Burbank. More physicians and patients can now benefit from access to Quest’s advanced and …

Mercator MedSystems announced completion of enrollment today in the company’s LIMBO-ATX (Lower-Limb Adventitial Infusion of Dexamethasone via Bullfrog to Reduce Occurrence of Restenosis after Atherectomy-Based Revascularization) clinical trial. The LIMBO-ATX trial was designed to use Mercator’s proprietary Bullfrog® micro-infusion catheter to test a new treatment strategy to potentially improve blood flow and decrease repeat revascularization procedures in below-the-knee (BTK) critical …